- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- March 2025
- 150 Pages
Global
From €2866EUR$3,250USD£2,472GBP
€4277EUR$4,850USD£3,689GBP
- Report
- May 2025
- 100 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- August 2024
- 100 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- May 2025
- 185 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- May 2025
- 192 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
From €4321EUR$4,900USD£3,727GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- January 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 393 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- July 2025
- 281 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- July 2025
- 193 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,765GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,765GBP
- Report
- September 2024
- 132 Pages
Global
From €7011EUR$7,950USD£6,048GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2205EUR$2,500USD£1,902GBP

Olanzapine is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and depression. It is a member of the atypical antipsychotic class of drugs, which are used to treat the symptoms of mental health conditions. Olanzapine works by blocking certain receptors in the brain, which helps to reduce the symptoms of mental health conditions. It is also used to treat agitation and aggression in people with dementia.
Olanzapine is a widely used medication in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, and is often prescribed as a first-line treatment for schizophrenia. It is also used to treat other mental health conditions, such as bipolar disorder and depression. Olanzapine is generally well-tolerated, and has fewer side effects than other antipsychotic medications.
Some companies in the Olanzapine market include Eli Lilly, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more